Tumor-Infiltrating Lymphocyte Therapy for Melanoma: Nursing Considerations

Clinicians have used commercially available cellular therapy to treat hematologic malignancies since 2017. In February 2024, the U.S. Food and Drug Administration approved the first commercial cellular therapy-lifileucel, a.

Authors

Kristin Marie Ferguson
Farele Telfort
Celestine G Gochett

Institutions

Celanese (United States) (US)
Ferguson Library (US)

Publication Details

Journal: Clinical journal of oncology nursing
Published: 2025-03-14
DOI: https://doi.org/10.1188/25.cjon.125-129
Primary Topic: CAR-T cell therapy research
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Tumor-Infiltrating Lymphocyte Therapy for Melanoma: Nursing Considerations

Kristin Marie Ferguson, Farele Telfort, Celestine G Gochett

Mar 14, 2025

Clinical journal of oncology nursing

CAR-T cell therapy research

article

Tumor-Infiltrating Lymphocyte Therapy for Melanoma: Nursing Considerations

Kristin Marie Ferguson, Farele Telfort, Celestine G Gochett

March 14, 2025article en

Abstract

Clinical journal of oncology nursingVol. 29(2)

Celanese (United States) (US), Ferguson Library (US)

Openalex Percentile: Top 93%

CAR-T cell therapy research

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Tumor-Infiltrating Lymphocyte Therapy for Melanoma: Nursing Considerations — Kristin Marie Ferguson, Farele Telfort, et al. · Clinical journal of oncology nursing (2025) | TGRS Research Map | TGRS